Market Overview:
The global pets internal parasiticide market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of parasitic infections in pets, rising awareness about pet health and hygiene, and growing demand for internal parasiticide products. By type, the global market is segmented into tablets and powders. The tablets segment is expected to account for a larger share of the global market than powders during the forecast period. By application, dogs are expected to account for a larger share of the global market than cats and other animals during the forecast period.
Product Definition:
A Pets Internal Parasiticide is a medication used to kill internal parasites in pets. It is important to use a Pets Internal Parasiticide to kill any internal parasites that may be present in your pet, as they can cause serious health problems if left untreated.
Tablet:
Tablet is a form of medication that is administered to pets. It works by killing the parasites in the host (pet) body. There are two types of tablets available, namely semi-synthetic and synthetic. The type of tablet depends on its mode of action as it affects different types of parasites; for instance, ivermectin tables affect parasitic worms and thioglycolic acid tablets affect internal roundworm infection in dogs & cats among other animals too.
Powder:
Powder is a fine, white to off-white solid material that is produced commercially for the purpose of eliminating parasites. It consists of alfa-interferon and naloxone combination which are used in the treatment and prevention of parasitic infections in animals as well as humans. The drug has been approved by FDA for usage in dogs & cats over the counter (OTC) basis; it can be administered to pets without any medical consultation.
Application Insights:
The dogs segment held the largest share of more than 60.0% in 2017. The rising importance of pet ownership as a part of family and social life is expected to be one of the major factors driving demand for internal parasiticides in dogs over the forecast period. Moreover, an increase in spending on pets due to growing awareness about health and hygiene is anticipated to further fuel demand for internal parasiticide tablets and powders used for treating parasites inside cats and dogs over the forecast period.
Regional Analysis:
North America dominated the global pets internal parasiticide market in 2017. This is due to high pet ownership, increasing awareness about animal health and hygiene, and availability of effective treatment for pets at low cost. According to a survey conducted by the American Pet Products Association (APPA), around 68% of U.S households owned a companion animal in 2016; this number is likely to increase with time as more people are becoming aware of benefits associated with pet animals.
Asia Pacific is expected to witness lucrative growth over the forecast period owing its rapidly expanding population base coupled with growing disposable income levels especially among emerging economies such as India and China which have one of the highest rates for cat ownership worldwide along with Japan where dogs outnumber cats by almost 2:1 ratio).
Growth Factors:
- Increasing demand for internal parasite control products in pets owing to the growing awareness about the health benefits of such products.
- Rising prevalence of parasitic infections in pets, which is driving demand for internal parasite control products.
- Growing popularity of pet ownership, especially among millennials, who are increasingly becoming aware of the importance of preventive healthcare measures for their pets and are thus driving demand for internal parasite control products.
- Rapid expansion of the pet retail market, with a growing number of specialty stores offering a wide range of internal parasite control products catering to different needs and budgetsof pet owners.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pets Internal Parasiticide Market Research Report
By Type
Tablet, Powder
By Application
Dogs, Cats, Other
By Companies
Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Pets Internal Parasiticide Market Report Segments:
The global Pets Internal Parasiticide market is segmented on the basis of:
Types
Tablet, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Zoetis
- Merck
- Elanco
- Bayer
- Virbac
- Ceva Sante Animale
- Vetoquinol
- Bimeda Animal Health
- Chanelle
Highlights of The Pets Internal Parasiticide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Powder
- By Application:
- Dogs
- Cats
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pets Internal Parasiticide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pets Internal Parasiticide is a medication that kills parasites inside the body of your pet.
Some of the major players in the pets internal parasiticide market are Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle.
The pets internal parasiticide market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pets Internal Parasiticide Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pets Internal Parasiticide Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pets Internal Parasiticide Market - Supply Chain
4.5. Global Pets Internal Parasiticide Market Forecast
4.5.1. Pets Internal Parasiticide Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pets Internal Parasiticide Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pets Internal Parasiticide Market Absolute $ Opportunity
5. Global Pets Internal Parasiticide Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pets Internal Parasiticide Market Size and Volume Forecast by Type
5.3.1. Tablet
5.3.2. Powder
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pets Internal Parasiticide Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pets Internal Parasiticide Market Size and Volume Forecast by Application
6.3.1. Dogs
6.3.2. Cats
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pets Internal Parasiticide Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pets Internal Parasiticide Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pets Internal Parasiticide Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pets Internal Parasiticide Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pets Internal Parasiticide Demand Share Forecast, 2019-2026
9. North America Pets Internal Parasiticide Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pets Internal Parasiticide Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pets Internal Parasiticide Market Size and Volume Forecast by Application
9.4.1. Dogs
9.4.2. Cats
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pets Internal Parasiticide Market Size and Volume Forecast by Type
9.7.1. Tablet
9.7.2. Powder
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pets Internal Parasiticide Demand Share Forecast, 2019-2026
10. Latin America Pets Internal Parasiticide Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pets Internal Parasiticide Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pets Internal Parasiticide Market Size and Volume Forecast by Application
10.4.1. Dogs
10.4.2. Cats
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pets Internal Parasiticide Market Size and Volume Forecast by Type
10.7.1. Tablet
10.7.2. Powder
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pets Internal Parasiticide Demand Share Forecast, 2019-2026
11. Europe Pets Internal Parasiticide Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pets Internal Parasiticide Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pets Internal Parasiticide Market Size and Volume Forecast by Application
11.4.1. Dogs
11.4.2. Cats
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pets Internal Parasiticide Market Size and Volume Forecast by Type
11.7.1. Tablet
11.7.2. Powder
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pets Internal Parasiticide Demand Share, 2019-2026
12. Asia Pacific Pets Internal Parasiticide Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pets Internal Parasiticide Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pets Internal Parasiticide Market Size and Volume Forecast by Application
12.4.1. Dogs
12.4.2. Cats
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pets Internal Parasiticide Market Size and Volume Forecast by Type
12.7.1. Tablet
12.7.2. Powder
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pets Internal Parasiticide Demand Share, 2019-2026
13. Middle East & Africa Pets Internal Parasiticide Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pets Internal Parasiticide Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pets Internal Parasiticide Market Size and Volume Forecast by Application
13.4.1. Dogs
13.4.2. Cats
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pets Internal Parasiticide Market Size and Volume Forecast by Type
13.7.1. Tablet
13.7.2. Powder
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pets Internal Parasiticide Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pets Internal Parasiticide Market: Market Share Analysis
14.2. Pets Internal Parasiticide Distributors and Customers
14.3. Pets Internal Parasiticide Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zoetis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elanco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Virbac
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva Sante Animale
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Vetoquinol
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bimeda Animal Health
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chanelle
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
